Annals of Emergency Medicine
Volume 52, Issue 2 , Pages 160-164 , August 2008

Empirical Characteristics of Litigation Involving Tissue Plasminogen Activator and Ischemic Stroke

  • Bryan A. Liang, MD, PhD, JD

      Affiliations

    • Institute of Health Law Studies, California Western School of Law, San Diego, CA
    • San Diego Center for Patient Safety, San Diego, CA
    • Department of Anesthesiology, San Diego, CA
    • University of California San Diego, School of Medicine, La Jolla, CA
    • Graduate School of Public Health, College of Health and Human Services, San Diego State University, San Diego, CA.
    • Corresponding Author InformationAddress for reprints: Bryan A. Liang, MD, PhD, JD, Executive Director, Institute of Health Law Studies, California Western School of Law, Co-Director, San Diego Center for Patient Safety, UCSD School of Medicine, 350 Cedar Street, San Diego, CA 92101; 619-515-1568, fax 619-515-1599
    • ,
  • Justin A. Zivin, MD, PhD

      Affiliations

    • Department of Neurosciences, San Diego, CA

Received 15 July 2007 ,Revised 29 November 2007 ,Accepted 13 December 2007.

References 

  1. Demaerschalk BM. Thrombolytic therapy for acute ischemic stroke, the likelihood of being helped versus harmed. Stroke. 2007;38:2215–2216
  2. Brown DL, Barsan WG, Lisabeth LD, et al. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Ann Amerg Med. 2005;46:56–60
  3. Glauser J. Will EPs' reluctance to embrace thrombolysis for stroke lead to lawsuits [part I]?. Emerg Med News. 2006;28:23–25
  4. Glauser J. Will EPs' reluctance to embrace thrombolysis for stroke lead to lawsuits [part II]?. Emerg Med News. 2006;28:28–29
  5. Glauser J. Stroke and the emergency physician: is tPA standard of care?. Emerg Med News. 2007;29:1;24-25
  6. Kleindorfer D, Kissela B, Schneider A, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke. 2004;35:e27–e29
  7. Schneider SM, Goldstein LB, Adams JG, et al. Incentives for enhancing stroke care. In: A National Institute of Neurological Disorders and Stroke Symposium: Improving the Chain of Recovery for Acute Stroke in Your Community—Task Force Reports. Bethesda, MD: National Institutes of Health, Department of Health and Human Services; 2002:71-80.
  8. Bambauer KZ, Johnston C, Bambauer DE, et al. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol. 2006;63:661–664
  9. Weintraub MI. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Stroke. 2006;37:1917–1922
  10. Liang BA. Layperson and physician perceptions of the malpractice system: implications for patient safety. Soc Sci Med. 2003;57:147–153

 Supervising editor: Robert Silbergleit, MD

 Author contributions: BAL and JAZ conceived the study, designed the methods, and assessed the data. BAL performed the database searches, reviewed the cases, collated the data, and wrote the primary drafts. BAL and JAZ reviewed the drafts, edited the article, and finalized it. Both authors take responsibility for the paper as a whole.

 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that my create any potential conflict of interest. The authors have stated that no such relationships exist. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement.

 Publication dates: Available online March 7, 2008.

PII: S0196-0644(07)01873-2

doi: 10.1016/j.annemergmed.2007.12.017

Annals of Emergency Medicine
Volume 52, Issue 2 , Pages 160-164 , August 2008

Article Tools